494 related articles for article (PubMed ID: 26139298)
1. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
Duijvesz D; Versluis CY; van der Fels CA; Vredenbregt-van den Berg MS; Leivo J; Peltola MT; Bangma CH; Pettersson KS; Jenster G
Int J Cancer; 2015 Dec; 137(12):2869-78. PubMed ID: 26139298
[TBL] [Abstract][Full Text] [Related]
2. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A
Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.
Hendriks RJ; Dijkstra S; Jannink SA; Steffens MG; van Oort IM; Mulders PF; Schalken JA
Clin Chem Lab Med; 2016 Mar; 54(3):483-92. PubMed ID: 26630694
[TBL] [Abstract][Full Text] [Related]
4. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
[TBL] [Abstract][Full Text] [Related]
5. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer biomarker profiles in urinary sediments and exosomes.
Dijkstra S; Birker IL; Smit FP; Leyten GH; de Reijke TM; van Oort IM; Mulders PF; Jannink SA; Schalken JA
J Urol; 2014 Apr; 191(4):1132-8. PubMed ID: 24211598
[TBL] [Abstract][Full Text] [Related]
7. Can urinary exosomes act as treatment response markers in prostate cancer?
Mitchell PJ; Welton J; Staffurth J; Court J; Mason MD; Tabi Z; Clayton A
J Transl Med; 2009 Jan; 7():4. PubMed ID: 19138409
[TBL] [Abstract][Full Text] [Related]
8. [Contamination of exosome preparations, isolated from biological fluids].
Grigor'eva AE; Dyrkheeva NS; Bryzgunova OE; Tamkovich SN; Chelobanov BP; Ryabchikova EI
Biomed Khim; 2017 Jan; 63(1):91-96. PubMed ID: 28251957
[TBL] [Abstract][Full Text] [Related]
9. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
11. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
[TBL] [Abstract][Full Text] [Related]
12. Magnetic bead-based isolation of exosomes.
Oksvold MP; Neurauter A; Pedersen KW
Methods Mol Biol; 2015; 1218():465-81. PubMed ID: 25319668
[TBL] [Abstract][Full Text] [Related]
13. Urinary biomarkers of prostate cancer.
Fujita K; Nonomura N
Int J Urol; 2018 Sep; 25(9):770-779. PubMed ID: 30129068
[TBL] [Abstract][Full Text] [Related]
14. A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy.
Zhang W; Ren SC; Shi XL; Liu YW; Zhu YS; Jing TL; Wang FB; Chen R; Xu CL; Wang HQ; Wang HF; Wang Y; Liu B; Li YM; Fang ZY; Guo F; Lu X; Shen D; Gao X; Hou JG; Sun YH
Prostate; 2015 May; 75(6):653-61. PubMed ID: 25597901
[TBL] [Abstract][Full Text] [Related]
15. A three-gene panel on urine increases PSA specificity in the detection of prostate cancer.
Rigau M; Ortega I; Mir MC; Ballesteros C; Garcia M; Llauradó M; Colás E; Pedrola N; Montes M; Sequeiros T; Ertekin T; Majem B; Planas J; Ruiz A; Abal M; Sánchez A; Morote J; Reventós J; Doll A
Prostate; 2011 Dec; 71(16):1736-45. PubMed ID: 21520154
[TBL] [Abstract][Full Text] [Related]
16. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers.
Skotland T; Ekroos K; Kauhanen D; Simolin H; Seierstad T; Berge V; Sandvig K; Llorente A
Eur J Cancer; 2017 Jan; 70():122-132. PubMed ID: 27914242
[TBL] [Abstract][Full Text] [Related]
17. Identification of prostate cancer biomarkers in urinary exosomes.
Øverbye A; Skotland T; Koehler CJ; Thiede B; Seierstad T; Berge V; Sandvig K; Llorente A
Oncotarget; 2015 Oct; 6(30):30357-76. PubMed ID: 26196085
[TBL] [Abstract][Full Text] [Related]
18. Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
Kojima Y; Yoneyama T; Hatakeyama S; Mikami J; Sato T; Mori K; Hashimoto Y; Koie T; Ohyama C; Fukuda M; Tobisawa Y
PLoS One; 2015; 10(9):e0138520. PubMed ID: 26390303
[TBL] [Abstract][Full Text] [Related]
19. An immunoassay for urinary extracellular vesicles.
Salih M; Fenton RA; Knipscheer J; Janssen JW; Vredenbregt-van den Berg MS; Jenster G; Zietse R; Hoorn EJ
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F796-F801. PubMed ID: 26823283
[TBL] [Abstract][Full Text] [Related]
20. Ultrasensitive and Reversible Nanoplatform of Urinary Exosomes for Prostate Cancer Diagnosis.
Li P; Yu X; Han W; Kong Y; Bao W; Zhang J; Zhang W; Gu Y
ACS Sens; 2019 May; 4(5):1433-1441. PubMed ID: 31017389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
